Loading clinical trials...
Loading clinical trials...
The Effect of Virtual Reality on Patient Outcome in Coronary Angiography
This study explores the impact of virtual reality (VR) interventions on patient outcomes during coronary angiography procedures. It evaluates the effectiveness of VR in reducing patient anxiety, enhancing comfort, and improving overall satisfaction. The findings suggest that the use of VR as a non-pharmacological support tool can positively influence patients' emotional states, reduce perceived stress levels, and potentially improve cooperation during the procedure. These results highlight the potential of immersive technologies to support patient-centered care in interventional cardiology settings.
Coronary angiography is an essential diagnostic and interventional procedure widely used to assess coronary artery disease. Despite its clinical importance, many patients experience significant levels of anxiety, stress, and discomfort before and during the procedure, which can negatively impact their physiological responses and overall satisfaction. In recent years, non-pharmacological interventions, particularly immersive technologies such as virtual reality (VR), have been investigated for their potential to enhance the patient experience during medical procedures. This study aimed to evaluate the effect of virtual reality on patient outcomes during coronary angiography. A controlled clinical trial design was employed to compare a group of patients exposed to a VR intervention-typically involving calming, immersive environments-against a control group receiving standard care. Key outcome measures included anxiety levels, pain perception, and overall patient satisfaction. The study supports the integration of virtual reality as a complementary tool in cardiac catheterization laboratories to improve patient-centered outcomes. As technology becomes increasingly accessible, VR-based interventions may offer innovative solutions to reduce procedural stress and improve the quality of care in invasive cardiology.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Van YYÜ Univercity
Van, Van, Turkey (Türkiye)
Start Date
March 1, 2025
Primary Completion Date
August 8, 2025
Completion Date
August 30, 2025
Last Updated
December 12, 2025
64
ACTUAL participants
intervention group
OTHER
standard care and treatment.
OTHER
Lead Sponsor
HARUN ÜNAL
NCT06346132
NCT07457788
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions